Successful treatment of severe anti-p200 pemphigoid in a heart transplant recipient with a single cycle of rituximab - Archive ouverte HAL Access content directly
Journal Articles JAAD Case reports Year : 2017

Successful treatment of severe anti-p200 pemphigoid in a heart transplant recipient with a single cycle of rituximab

(1) , (1, 2) , (1) , (3) , (1) , (1, 4)
1
2
3
4

Abstract

Anti-p200 pemphigoid is a rare autoimmune subepidermal blistering disease, first described in 1996.1 This disorder was initially considered as a more benign condition compared with bullous pemphigoid and epidermolysis bullosa acquisita, but in a recent series of patients, heterogeneous clinical presentations have been described, including cases with a more severe course than previously reported.2 We describe a case with a highly active disease in a heart transplant patient who experienced a dramatic and complete remission after 1 cycle of rituximab.
Fichier principal
Vignette du fichier
Successful treatment of severe anti-p200.pdf (424.85 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

hal-01518892 , version 1 (03-05-2018)

Licence

Attribution - NoDerivatives - CC BY 4.0

Identifiers

Cite

Lisa Rousseau, Catherine Droitcourt, Nolwenn Ropars, Bernard Lelong, Clémence Saillard, et al.. Successful treatment of severe anti-p200 pemphigoid in a heart transplant recipient with a single cycle of rituximab. JAAD Case reports, 2017, 3 (3), pp.175-177. ⟨10.1016/j.jdcr.2017.01.028⟩. ⟨hal-01518892⟩
305 View
71 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More